THROMBOVIEW Trademark

Trademark Overview

On Tuesday, March 4, 2008, a trademark application was filed for THROMBOVIEW with the United States Patent and Trademark Office. The USPTO has given the THROMBOVIEW trademark a serial number of 79055624. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, September 21, 2023. This trademark is owned by Agen Biomedical Limited; ACN 010 528 980. The THROMBOVIEW trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic imaging agents, namely, diagnostic imaging agents for visualising blood clots
thromboview

General Information

Serial Number79055624
Word MarkTHROMBOVIEW
Filing DateTuesday, March 4, 2008
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, September 21, 2023
Registration Number3623212
Registration DateTuesday, May 19, 2009
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 3, 2009

Trademark Statements

Goods and ServicesDiagnostic imaging agents, namely, diagnostic imaging agents for visualising blood clots
Pseudo MarkTHROMBO VIEW

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateMonday, September 23, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAgen Biomedical Limited; ACN 010 528 980
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAU
Party NameAgen Biomedical Limited; ACN 010 528 980
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAU
Party NameAgen Biomedical Limited; ACN 010 528 980
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAU

Trademark Events

Event DateEvent Description
Monday, August 4, 2008ASSIGNED TO EXAMINER
Thursday, July 31, 2008SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Friday, August 1, 2008LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Monday, August 4, 2008NEW APPLICATION ENTERED
Wednesday, August 13, 2008NON-FINAL ACTION WRITTEN
Thursday, August 14, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, August 14, 2008REFUSAL PROCESSED BY MPU
Thursday, August 14, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 12, 2008REFUSAL PROCESSED BY IB
Wednesday, January 14, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 14, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 14, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 15, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 28, 2009ASSIGNED TO LIE
Wednesday, January 28, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 11, 2009NOTICE OF PUBLICATION
Tuesday, March 3, 2009PUBLISHED FOR OPPOSITION
Tuesday, May 19, 2009REGISTERED-PRINCIPAL REGISTER
Wednesday, August 19, 2009FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 1, 2009FINAL DISPOSITION PROCESSED
Tuesday, September 1, 2009FINAL DISPOSITION NOTICE SENT TO IB
Friday, November 13, 2009FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, April 10, 2014DEATH OF INTERNATIONAL REGISTRATION
Thursday, April 10, 2014NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Thursday, October 2, 2014CORRECTION TRANSACTION RECEIVED FROM IB
Friday, October 3, 2014CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, July 1, 2016NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Saturday, May 20, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, April 23, 2024DEATH OF INTERNATIONAL REGISTRATION
Tuesday, April 23, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Monday, June 17, 2024UNDELIVERABLE MAIL - NO ACTION TAKEN

Related Keywords

thromboview diagnostic agents imaging clots blood namely visualising